New studies have shown that ibogaine’s mechanism of action inhibits nicotinic acetylcholine receptors (nAChRs). Nicotinic acetylcholine receptors are associated with different neurobiological processes, which include releasing neurotransmitters for example dopamine, that happen to be intensely associated with the brain’s reward and satisfaction